182 related articles for article (PubMed ID: 23675978)
1. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
Yadav DK; Kalani K; Khan F; Srivastava SK
Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978
[TBL] [Abstract][Full Text] [Related]
2. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7.
Yadav DK; Kalani K; Singh AK; Khan F; Srivastava SK; Pant AB
Curr Med Chem; 2014; 21(9):1160-70. PubMed ID: 24180274
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.
Li Y; Feng L; Song ZF; Li HB; Huai QY
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861280
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
Jin L; Huang R; Huang X; Zhang B; Ji M; Wang H
Bioorg Med Chem; 2018 May; 26(8):1759-1775. PubMed ID: 29486954
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antiproliferative Activity of Novel A-Ring Cleaved Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416117
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791593
[TBL] [Abstract][Full Text] [Related]
13. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
[TBL] [Abstract][Full Text] [Related]
14. An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents.
Xu B; Wu GR; Zhang XY; Yan MM; Zhao R; Xue NN; Fang K; Wang H; Chen M; Guo WB; Wang PL; Lei HM
Molecules; 2017 Jun; 22(6):. PubMed ID: 28574470
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.
Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY
Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357
[TBL] [Abstract][Full Text] [Related]
16. QSAR guided semi-synthesis and in-vitro validation of anticancer activity in ursolic acid derivatives.
Kalani K; Yadav DK; Singh A; Khan F; Godbole MM; Srivastava SK
Curr Top Med Chem; 2014; 14(8):1005-13. PubMed ID: 24660684
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Silico Studies of Glycyrrhetinic Acid Derivatives as Anti- Filarial Agents.
Tyagi R; Verma S; Mishra S; Srivastava M; Alam S; Khan F; Srivastava SK
Curr Top Med Chem; 2019; 19(14):1191-1200. PubMed ID: 31210109
[TBL] [Abstract][Full Text] [Related]
18. A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides.
Schwarz S; Siewert B; Xavier NM; Jesus AR; Rauter AP; Csuk R
Eur J Med Chem; 2014 Jan; 72():78-83. PubMed ID: 24361520
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
Jin L; Zhang B; Hua S; Ji M; Huang X; Huang R; Wang H
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3700-3707. PubMed ID: 30528976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
